Lakeside Holding LTD 8-K filings

Lakeside Holding Limited received a notification from Nasdaq regarding non-compliance with minimum stockholders' equity requirements for continued listing.

Lakeside Holding Limited announces a decrease in total revenues for Q2 2025, driven by a decline in cross-border airfreight solutions, while highlighting strategic progress in pharmaceutical logistics and Asia-based customer growth.

Lakeside Holding Limited has announced the resignation of its Chief Operating Officer, Shuai Li, and the appointment of Lan Su as the new COO, both effective December 9, 2024.

Lakeside Holding's first quarter of fiscal year 2025 saw a slight revenue decrease overall, but a significant increase in revenue from Asia-based customers.

Lakeside Holding Limited's subsidiary, Sichuan Hupan, has agreed to acquire 100% of Hupan Pharmaceutical for RMB 4.0 million (approximately $0.6 million USD).

Lakeside Holding Limited reported a 42.3% increase in total revenue for fiscal year 2024, driven by a significant surge in airfreight revenues.